Precision medicine refers to the use of molecular information to guide disease prevention, health promotion and/or treatment. Programs such as the White House's Precision Medicine Initiative and the NCI Cancer Moonshot support "a new era of medicine through research, technology, and policies that empower patients, researchers, and providers to work together toward development of individualized care."
Since cancer is a genetic disease, CancerPOP uses molecular genetics and computational biology to weigh different treatment options and find new options.
Next-Generation DNA Sequencing
Next-generation sequencing of DNA is a new technology that rapidly reads the sequence of A's, T's, C's and G's in the DNA. Next-generation sequencing can be used to read
- a small list of genes suspected in causing a disease (also called a gene panel),
- the portions of DNA responsible for coding all proteins (also called the exome), or
- the entire DNA (also called the genome).
Your CancerPOP team will help decide which kind of next-generation sequencing fits your needs.
Pharmacogenetics is the study of how our inherited genes influence the way we metabolize drugs. With genetic information, CancerPOP identifies drugs that may be affected by inherited genetics. If a drug is poorly metabolized, then the drug may cause severe side effects. This information would be helpful to know in advance.